MIKAN GEORGE LAWRENCE III (CEO & President) sold 13.5% of their position (12.98K shares) of NEUEHEALTH, INC. on the open market
Open‑market sale worth $120.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/11/2024ACC: 0001628280-24-010352
DirectorOfficer· CEO & President
Since Jun 2021
-12.98K
Net shares
Net seller
$120.8K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
7.57K acquired · 20.55K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+7.57K
Price / share
—
Trade value
—
% of position
8.5%
3/7/2024
88.80K→96.37K
Common Stock
Direct
Shares
−7.89K
Price / share
$9.88
Trade value
$77.91K
% of position
8.2%
3/7/2024
96.37K→88.48K
Common Stock
Direct
Shares
−5.10K
Price / share
$8.42
Trade value
$42.91K
% of position
5.8%
3/8/2024
88.48K→83.39K
Total
Net shares
−5.42K
Net value
-$120.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/7/2024 | M · Option Exercise | +7.57K | — | — | 8.5% | 88.80K | 96.37K |
| Common Stock Direct | 3/7/2024 | S · Sale | −7.89K | $9.88 | $77.91K | 8.2% | 96.37K | 88.48K |
| Common Stock Direct | 3/8/2024 | S · Sale | −5.10K | $8.42 | $42.91K | 5.8% | 88.48K | 83.39K |
| Total | −5.42K | -$120.82K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
7.57K shares
Shares
−7.57K
Strike price
Held after
7.57K
Exercisable
—
3/7/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock7.57K shares | 3/7/2024 | M · Option Exercise | −7.57K | — | 7.57K |